Scholar Rock Holding SRRK
NASDAQ SRRK
$43.00 +1.64 (+3.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Current Leases (2018)

Updated

Scholar Rock Holding (SRRK) reported Current Leases of $14,000 for Q3 2018.

Analysis

Scholar Rock Holding (SRRK) Current Leases (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Scholar Rock Holding 5.61 Bn 3.90 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 14,000.00
API Access

Scholar Rock Holding Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SRRK&period=max&api_key=YOUR_API_KEY